News
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Zomedica announces webinar showcasing manufacturing operations for investors, providing insight into quality systems and scalable product fulfillment -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Zomedica Corp. announces collaboration with Boehringer Ingelheim Animal Health USA Inc. to enhance early detection along with treatment and monitoring of pituitary pars intermedia dysfunction (PPID) in horses -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Zomedica reports record $10 million quarterly revenue, 20th consecutive year-over-year growth. Financial highlights and strategic outlook unveiled -
